Zoledronic acid: the trump card in osteoporosis?

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1645, 2008-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Statins a potential treatment for osteoporosis?

Inpharma, Vol. 1, Iss. 1244, 2000-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Antiretrovirals: Osteoporosis?: case report

Reactions Weekly, Vol. 1, Iss. 1383, 2012-01 ,pp. : 8-9

Adis International

Access to resources Recommend Favorite

Which therapies warranted for postmenopausal osteoporosis?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 370, 2002-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Osteoporosis treatment: why ibandronic acid?

By Rossini Maurizio Orsolini Giovanni Adami Silvano Kunnathully Vidya Gatti Davide

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 10, 2013-07 ,pp. : 1371-1381

Informa Healthcare

Access to resources Recommend Favorite

Docetaxel/zoledronic acid: Thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome in an elderly patient?: case report

Reactions Weekly, Vol. 1, Iss. 1381, 2011-01 ,pp. : 12-13

Adis International

Access to resources Recommend Favorite